Streetbeat News

Stock Prices

LLY

NVO

A study published in JAMA Network Open reveals that Novo Nordisk's older weight-loss drug Saxenda (liraglutide) is associated with decreased bone mass density. The study raises concerns about similar effects in newer treatments like Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 6:12 pm

KLAC

KLA shares are trading higher amid a rebound in chip stocks.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 6:10 pm

NVST

Envista Holdings (NYSE:NVST) has been analyzed by 5 analysts over the past three months, showing a range of ratings from bullish to bearish. The average 12-month price target has decreased to $19.9, down 22.27% from the previous $25.60. Analysts have recently lowered their ratings and price targets for NVST, reflecting a cautious outlook.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

GE

Deep-pocketed investors have adopted a bearish approach towards GE Aero (NYSE:GE), with significant options activity indicating a potential price range of $160.0 to $175.0. The majority of the options trades are bearish, with 7 puts totaling $308,790 and 3 calls amounting to $179,328. The current trading volume is 2,317,494, with GE's price up by 1.8% at $163.43. An analyst from Deutsche Bank maintains a Buy rating with a target price of $209.0.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

ALB

Deep-pocketed investors have adopted a bearish approach towards Albemarle (NYSE:ALB), as revealed by Benzinga's options scanner. The majority of the options activity is bearish, with significant puts and calls indicating a price range of $90.0 to $120.0. The stock is currently down 3.33% at $93.19, and analysts have mixed ratings with a consensus target price of $109.5.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

ADSK

Autodesk (NASDAQ:ADSK) has outperformed the market over the past 20 years with an average annual return of 12.96%, resulting in a $1000 investment growing to $11,377.80. The company currently has a market capitalization of $51.90 billion.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

GD

General Dynamics (NYSE:GD) has outperformed the market over the past 20 years with an average annual return of 9.43%, resulting in a $100 investment growing to $603.52. The company currently has a market capitalization of $81.13 billion.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 6:01 pm

ARWR

Arrowhead Pharmaceuticals is advancing its investigational drug Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial, following positive results from the Phase 2 MUIR study. The CAPITAN trial will focus on patients with mixed hyperlipidemia and residual risk of atherosclerotic cardiovascular disease. Arrowhead is also considering partnership options for the future development of Zodasiran.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 5:58 pm

AVGO

NVDA

Broadcom Inc (NASDAQ:AVGO) announced updates to its VMware Cloud Foundation, enhancing infrastructure modernization, developer productivity, and cybersecurity. Analysts highlight Broadcom's strong position in the AI semiconductor market, predicting significant revenue growth.

Portfolio Pulse from Anusuya Lahiri

June 25, 2024 | 5:58 pm

AMZN

MSFT

PLTR

SPY

VOO

Reddit users on r/stocks debated where to invest $4,900, with recommendations including Microsoft, Amazon, and ETFs like SPDR S&P 500 ETF and Vanguard S&P 500 ETF. Microsoft and Amazon were highlighted for their strong fundamentals and growth potential, while Palantir sparked mixed opinions.

Portfolio Pulse from Surbhi Jain

June 25, 2024 | 5:56 pm